Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors
Clinical trial NCT01892046 · COMPLETED
Trial details
- NCT number
- NCT01892046
- Sponsor
- Esanex Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2017-02-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.